top of page
Helaina
Helaina raises $45m to speed-up commercialisation of human bioactive proteins
US biotech start-up Helaina has raised $45 million in a Series B funding round led by investment firm Avidity Partners.
- Page 1
bottom of page
US biotech start-up Helaina has raised $45 million in a Series B funding round led by investment firm Avidity Partners.